Video

Dr. Lilenbaum on the Challenges of Integrating Telehealth Services in Lung Cancer

Rogerio C. Lilenbaum, MD, discusses the challenges of integrating telehealth services in lung cancer.

Rogerio C. Lilenbaum, MD, director, Banner MD Anderson Cancer Center, discusses the challenges of integrating telehealth services in lung cancer.

In the era of the coronavirus disease 2019 (COVID-19), telehealth has become a key tool in the continuum of patient care. However, despite best efforts to streamline virtual care before the COVID-19 pandemic, challenges remain in utilizing telehealth to its full potential, says Lilenbaum.

Although many of these hurdles have been overcome over the course of the pandemic, it is not fully understood what role telemedicine will play in cancer care after the pandemic, concludes Lilenbaum.

Related Videos
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, on progression patterns and subsequent therapies after lorlatinib in ALK-positive NSCLC.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss preclinical CNS data for the ROS1 inhibitor zidesamtinib.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for zidesamtinib in ROS1-positive non–small cell lung cancer.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for NVL-655 in ALK-positive NSCLC and other ALK-positive solid tumors.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss testing for ALK-positive and ROS1-positive non–small cell lung cancer.
Nicolas Girard, MD
Sally Lau, MD
Andrea Wolf, MD, MPH
Jacob Sands, MD
Marina Chiara Garassino, MD